iCAD, Inc. Reported Preliminary Q4 Revenue Missed The Estimates
<p><a href='https://financialmodelingprep.com/financial-summary/ICAD'>iCAD, Inc. (NASDAQ:ICAD) </a>reported its preliminary Q4 results, with sales coming in at $7.8–8.0 million, missing the Street estimate of $10.7 million. According to the company, the disruptions in quarterly revenue were primarily because of the surge of Omicron in December leading to clinical and administrative staffing shortages. </p>
<p>Despite the negative preliminary results, the analysts at Oppenheimer mentioned that they are encouraged by the company's decision to gradually implement a subscription sales model starting in Q1/22 and re-organize its sales functions. </p>
NASDAQ:ICAD